Updated Jul 16, 2026
Glastra Matthijs has filed 6 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $11.41M.
Matthijs Glastra is the Chief Executive Officer and Director of Novanta Inc, a company specializing in photonic and motion-control components for medical and industrial applications. He has been involved in leading the company's strategic direction and growth in the medical technology sector.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | NOVT | NOVANTA INC | S — Open-market sale | 200 | $164.20 | $33K |
| 2026-07-07 | NOVT | NOVANTA INC | S — Open-market sale | 437 | $163.71 | $72K |
| 2026-07-07 | NOVT | NOVANTA INC | S — Open-market sale | 1.2K | $162.01 | $189K |
| 2026-07-07 | NOVT | NOVANTA INC | S — Open-market sale | 1.7K | $161.28 | $270K |
| 2026-07-07 | NOVT | NOVANTA INC | S — Open-market sale | 3.0K | $160.13 | $484K |
| 2026-06-04 | NOVT | NOVANTA INC | S — Open-market sale | 400 | $171.28 | $69K |
| 2026-06-04 | NOVT | NOVANTA INC | S — Open-market sale | 1.3K | $169.76 | $221K |
| 2026-06-04 | NOVT | NOVANTA INC | S — Open-market sale | 2.8K | $168.76 | $479K |
| 2026-06-04 | NOVT | NOVANTA INC | S — Open-market sale | 1.4K | $167.68 | $238K |
| 2026-06-04 | NOVT | NOVANTA INC | S — Open-market sale | 500 | $166.19 | $83K |
| 2026-06-04 | NOVT | NOVANTA INC | S — Open-market sale | 38 | $164.61 | $6K |
| 2026-05-14 | NOVT | NOVANTA INC | S — Open-market sale | 2.4K | $151.34 | $366K |
| 2026-05-14 | NOVT | NOVANTA INC | S — Open-market sale | 5.1K | $150.00 | $762K |
| 2026-05-08 | IEX | IDEX CORP /DE/ | A — Grant or award | 805 | $0.00 | |
| 2026-05-07 | NOVT | NOVANTA INC | S — Open-market sale | 23 | $133.27 | $3K |
| 2026-05-07 | NOVT | NOVANTA INC | S — Open-market sale | 1.2K | $132.51 | $156K |
| 2026-05-07 | NOVT | NOVANTA INC | S — Open-market sale | 1.0K | $131.75 | $135K |
| 2026-05-07 | NOVT | NOVANTA INC | S — Open-market sale | 4.3K | $130.59 | $558K |
| 2026-04-21 | NOVT | NOVANTA INC | S — Open-market sale | 6.5K | $130.05 | $845K |
| 2026-03-04 | NOVT | NOVANTA INC | S — Open-market sale [10b5-1] | 1.8K | $140.48 | $252K |
Matthijs Glastra is the Chief Executive Officer and Director of Novanta Inc, a company specializing in photonic and motion-control components for medical and industrial applications. He has been involved in leading the company's strategic direction and growth in the medical technology sector.…
6 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 43 open-market sales ($11.41M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Glastra Matthijs profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.